SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: D.Right who wrote (662)9/9/1997 8:07:00 AM
From: tonyt   of 2173
 
The funny thing is that henry points the Amylin thread to "thestreet.com", and the article points right back to henry -- "Ligand's partnership plans for a new diabetes drug have become the hot topic among Internet chatterboxes" (guess who they were referring to as a 'chatterbox'). Henry starts a rumor about LGND and J&J, "the street" picks it up as a 'hot topic among Internet chatterboxes', then henry points to it as substantiation for his rumor (now I know why he didn't post the article). He also mislead us by saying it was "thestreets" top story, when the top story was in fact "Wall Streets love affair to Ravioli".

--Tony
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext